Jonathan M. Wilson

A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes

Monika A. Niewczas, Meda E. Pavkov, Jan Skupień et al. · Nature Medicine · 2019 · 420 citations · Full text

Immunology, Renal Inflammation, Pathology +16

Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes

Melissa K. Thomas, Amir Nikooienejad, Ross Bray et al. · The Journal of Clinical Endocrinology & Metabolism · 2020 · 300 citations · Full text

The dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes

Jonathan M. Wilson, Amir Nikooienejad, Deborah A. Robins et al. · Diabetes Obesity and Metabolism · 2020 · 148 citations · Full text

Circulating αKlotho influences phosphate handling by controlling FGF23 production

Rosamund C. Smith, Linda M. O’Bryan, Emily Farrow et al. · Journal of Clinical Investigation · 2012 · 147 citations · Full text

Human Growth, Pathology, Cellular Physiology +26

The dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: A p <scp>ost hoc</scp> analysis

Jonathan M. Wilson, Yanzhu Lin, Mengdie Luo et al. · Diabetes Obesity and Metabolism · 2021 · 113 citations · Full text